The predictive and prognostic value of sex in early-stage colon cancer: A pooled analysis of 33,345 patients from the ACCENT database

Clinical Colorectal Cancer

Volumn 12, Issue 3, 2013, Pages 179-187

  Cheung, Winson Y ^a   Shi, Qian ^b   O'Connell, Michael ^c   Cassidy, James ^d   Blanke, Charles D ^e   Kerr, David J ^f   Meyers, Jeff ^b   Van Cutsem, Eric ^g   Alberts, Steven R ^b   Yothers, Greg ^b   Sargent, Daniel J ^b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b MAYO CLINIC   (United States)

^c NSABP Foundation Inc   (United States)

^d HOFFMANN LA ROCHE INC   (United States)

^e Southwest Oncology Group   (United States)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Colon cancer; Outcomes; Sex; Survival

Indexed keywords

FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; COLON CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; EARLY CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL (TOPIC); SEX DIFFERENCE;

COLON CANCER; OUTCOMES; SEX; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PROGNOSIS; SEX FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 84883160244     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2013.04.004     Document Type: Article

References (27)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. B.K. Edwards, E. Ward, and B.A. Kohler Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates Cancer 116 2010 544 573
3. G. Yothers, M.J. O'Connell, and C.J. Allegra Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses J Clin Oncol 29 2011 3768 3774
4. D.G. Haller, J. Tabernero, and J. Maroun Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer J Clin Oncol 29 2011 1465 1471
5. T. Andre, C. Boni, and M. Navarro Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial J Clin Oncol 27 2009 3109 3116
6. J.P. Kuebler, H.S. Wieand, and M.J. O'Connell Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07 J Clin Oncol 25 2007 2198 2204
7. T. Andre, C. Boni, and L. Mounedji-Boudiaf Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 2004 2343 2351
8. E.C. Paulson, C. Wirtalla, and K. Armstrong Gender influences treatment and survival in colorectal cancer surgery Dis Colon Rectum 52 2009 1982 1991
9. J.H. Koo, B. Jalaludin, and S.K. Wong Improved survival in young women with colorectal cancer Am J Gastroenterol 103 2008 1488 1495
10. B.L. van Leeuwen, L. Pahlman, and U. Gunnarsson The effect of age and gender on outcome after treatment for colon carcinoma. A population-based study in the Uppsala and Stockholm region Crit Rev Oncol Hematol 67 2008 229 236
11. C.S. McArdle, D.C. McMillan, and D.J. Hole Male gender adversely affects survival following surgery for colorectal cancer Br J Surg 90 2003 711 715
12. M.W. Wichmann, C. Muller, and H.M. Hornung Gender differences in long-term survival of patients with colorectal cancer Br J Surg 88 2001 1092 1098
13. T. Watanabe, T.T. Wu, and P.J. Catalano Molecular predictors of survival after adjuvant chemotherapy for colon cancer N Engl J Med 344 2001 1196 1206
14. J.A. Sloan, R.M. Goldberg, and D.J. Sargent Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer J Clin Oncol 20 2002 1491 1498
15. J.A. Sloan, C.L. Loprinzi, and P.J. Novotny Sex differences in fluorouracil-induced stomatitis J Clin Oncol 18 2000 412 420
16. S. Cascinu, S. Barni, and R. Labianca Evaluation of factors influencing 5-fluorouracil-induced diarrhea in colorectal cancer patients. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) study Support Care Cancer 5 1997 314 317
17. J.L. Lagrange, B. Medecin, and M.C. Etienne Cisplatin nephrotoxicity: a multivariate analysis of potential predisposing factors Pharmacotherapy 17 1997 1246 1253
18. G. Milano, M.C. Etienne, and E. Cassuto-Viguier Influence of sex and age on fluorouracil clearance J Clin Oncol 10 1992 1171 1175
19. H.I. Meissner, N. Breen, and C.N. Klabunde Patterns of colorectal cancer screening uptake among men and women in the United States Cancer Epidemiol Biomarkers Prev 15 2006 389 394
20. J. Wardle, A. Miles, and W. Atkin Gender differences in utilization of colorectal cancer screening J Med Screen 12 2005 20 27
21. P. Wheatley-Price, F. Blackhall, and S.M. Lee The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials Ann Oncol 21 2010 2023 2028
22. P. Wheatley-Price, A. Le Maitre, and K. Ding The influence of sex on efficacy, adverse events, quality of life, and delivery of treatment in national cancer institute of canada clinical trials group non-small cell lung cancer chemotherapy trials J Thorac Oncol 5 2010 640 648
23. S. Singh, W. Parulekar, and N. Murray Influence of sex on toxicity and treatment outcome in small-cell lung cancer J Clin Oncol 23 2005 850 856
24. G. Hutchins, K. Southward, and K. Handley Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer J Clin Oncol 29 2011 1261 1270
25. A. Hendifar, D. Yang, and F. Lenz Gender disparities in metastatic colorectal cancer survival Clin Cancer Res 15 2009 6391 6397
26. J.A. Chan, J.A. Meyerhardt, and A.T. Chan Hormone replacement therapy and survival after colorectal cancer diagnosis J Clin Oncol 24 2006 5680 5686
27. C.D. Venturini, P. Engroff, and L.S. Ely Gender differences, polypharmacy, and potential pharmacological interactions in the elderly Clinics (Sao Paulo) 66 2011 1867 1872